7139-02-08: Dipyridamole EP Impurity G

Dipyridamole EP Impurity G (CAS No.: 7139-02-8) or 2,6-Dichloro-4,8-di(piperidin-1-yl)-pyrimido[5,4-d]pyrimidine was evaluated for study during the study of development and validation for related substances of tartaric acid-base pellets of dipyridamole modified release capsules by using high-performance liquid chromatography.

Additional information on CAS 2/8/7139

Catalogue No.

VL47007

CAS No.

2/8/7139

Molecular Formula

C16H20Cl2N6

Molecular Weight

367.27

Parent drug

Dipyridamole

IUPAC Name

2, 6-Dichloro-4, 8-di(piperidin-1-yl)pyrimido[5, 4-d]pyrimidine

Synonyms

2, 6-Dichloro-4, 8-di-1-piperidinyl-pyrimido[5, 4-d]pyrimidine;

Status

In-stock

[rfq_list]

Login first to add product to RFQ List

Request a quote

7139-02-08: Dipyridamole EP Impurity G

7139-02-08: Dipyridamole EP Impurity G
Catalogue No.

VL47007

CAS No.

2/8/7139

Molecular Formula

C16H20Cl2N6

Molecular Weight

367.27

Parent drug

Dipyridamole

IUPAC Name

2, 6-Dichloro-4, 8-di(piperidin-1-yl)pyrimido[5, 4-d]pyrimidine

Synonyms

2, 6-Dichloro-4, 8-di-1-piperidinyl-pyrimido[5, 4-d]pyrimidine;

References

Sriram Valavala, et al. “Development and Validation for Related Substances of Tartaric Acid Base Pellets of Dipyridamole Modified…” ResearchGate, unknown, 2017, http://www.researchgate.net/publication/320103219_Development_and_Validation_for_Related_Substances_of_Tartaric_Acid_Base_Pellets_of_Dipyridamole_Modified_Release_Capsules_by_Using_High_Performance_Liquid_Chromatography?enrichId=rgreq-f117ca0b898f3b073726dd4bd839daac-XXX&enrichSource=Y292ZXJQYWdlOzMyMDEwMzIxOTtBUzo1NjQ0NzQ1NDU0Mzg3MjBAMTUxMTU5

Status

In-stock

ListName

Dipyridamole EP Impurity G

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url
 
Hidden